Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
A meningioma is a benign (non-cancerous) tumor originating from the membranes covering the brain and spinal cord.
Meningiomas can occur in any age group.
They affect 2 in 100,000 people, but are much less common in children than in adults: they represent less than 1 percent of all brain tumors in children.
When they do affect children, meningiomas occur most often in the sixth and seventh years of life and are slightly more prevalent in boys than in girls.
As you read further below, you will find general information about meningiomas. If you would like to view summary information about brain tumors first, see the Dana-Farber/Children's Hospital Cancer Center overview on brain tumors.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches meningiomas
We hold a weekly brain tumor clinic for newly diagnosed patients currently receiving treatment. Each time you come for an appointment, you meet with every specialist on your child’s team, from your pediatric neuro-oncologist, neurologist, and neurosurgeon, to your pediatric endocrinologist, psycho-oncologist and school liaison.
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s Pediatric Brain Tumor Program offers your child the following services:
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”